• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Envoy Medical Inc.

    4/18/25 4:19:07 PM ET
    $COCH
    Industrial Specialties
    Health Care
    Get the next $COCH alert in real time by email
    DEFA14A 1 ea0238213-04.htm DEFINITIVE ADDITIONAL MATERIALS

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    ––––––––––––––––––––––––––––––––––

    SCHEDULE 14A

    ––––––––––––––––––––––––––––––––––

    Proxy Statement Pursuant to Section 14(a) (Rule 14a-101) of the
    Securities Exchange Act of 1934

    Filed by the Registrant

     

    ☒

    Filed by a Party other than the Registrant

     

    ☐

    Check the appropriate box:

    ☐

     

    Preliminary Proxy Statement

    ☐

     

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

     

    Definitive Proxy Statement

    ☒

     

    Definitive Additional Materials

    ☐

     

    Soliciting Material Pursuant to §240.14a-12

    Envoy Medical, Inc.
    (Name of Registrant as Specified in its Charter)

    –––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––

    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

    ☒

     

    No fee required.

    ☐

     

    Fee paid previously with preliminary materials.

    ☐

     

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

      

     

     

    CONTROL ID:

    REQUEST ID:

     

    ENVOY MEDICAL, INC

       
               

    IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
    for the Annual Meeting of Stockholders

     

    DATE:

    Wednesday, May 28, 2025

     
     

    TIME:

    3:00 PM Central Time

       
     

    LOCATION:

    Fairfield Inn & Suites, 1125 Co Rd E East, Vadnais Heights,
    MN 55110

               

    HOW TO REQUEST PAPER COPIES OF OUR MATERIALS

    PHONE: 
    Call toll free 
    1-866-752-8683

    FAX: 
    Send this card to 
    202-521-3464

    INTERNET:
    https://www.iproxydirect.com/Coch
    and follow the on-screen
    instructions
    .

    EMAIL:
    [email protected]
    Include your Control ID in your
    email.

               

    This communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement is available at: https://www.iproxydirect.com/COCH

    If you want to receive a paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy. To facilitate timely delivery please make the request, as instructed above, before May 14, 2025.

    you may enter your voting instructions at https://www.iproxydirect.com/COCH
    until 11:59 pm eastern time May 27, 2025.

       

    The purposes of this meeting are as follows:

    1.     To elect two Class II director nominees named in the Proxy Statement to the Envoy Medical Board of Directors, to serve until the earlier of the 2028 annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;

    2.     To ratify the appointment of Grant Thornton LLP as Envoy Medical’s independent registered public accounting firm for the year ending December 31, 2025;

    3.     To approve, on an advisory basis, the Company’s named executive officer (NEO) compensation;

    4.     To approve an amendment to the Envoy Medical, Inc. 2023 Equity Incentive Plan; and

    5.     to transact such other business as may properly come before the annual meeting or any adjustment thereof.

    Pursuant to Securities and Exchange Commission rules, you are receiving this Notice that the proxy materials for the Annual Meeting are available on the Internet. Follow the instructions above to view the materials and vote or request printed copies.

    The board of directors has fixed the close of business on April 10, 2025 as the record date for the determination of stockholders entitled to receive notice of the Annual Meeting and to vote the shares of our Class A common stock, par value $0.0001 per share, they held on that date at the meeting or any postponement or adjournment of the meeting.

    The Board of Directors recommends that you vote ‘for’ all proposals above.

    Please note — This is not a Proxy Card — you cannot vote by returning this card

     

           
             

    ENVOY MEDICAL, INC
    SHAREHOLDER SERVICES
    1 Glenwood Ave Suite 1001
    Raleigh NC 27603

         

    FIRST-CLASS MAIL  
    US POSTAGE
    PAID
    RALEIGH NC
    PERMIT # 870

             
             
             

    Time Sensitive shareholder information enclosed

       
             
             
             
             
             
             
             
             
             

    IMPORTANT SHAREHOLDER INFORMATION

           
             

    your vote is imporant

           
             
             
             
             
             
             
             
             
             
             
             

    ENVOY MEDICAL, INC
    SHAREHOLDER SERVICES
    1 Glenwood Ave Suite 1001
    Raleigh NC 27603

         

    FIRST-CLASS MAIL  
    US POSTAGE
    PAID
    RALEIGH NC
    PERMIT # 870

             

    Time Sensitive shareholder information enclosed

     

    IMPORTANT SHAREHOLDER
    INFORMATION

    your vote is imporant

     

    Get the next $COCH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $COCH

    DatePrice TargetRatingAnalyst
    6/24/2024$8.50Buy
    Ascendiant Capital Markets
    More analyst ratings

    $COCH
    SEC Filings

    See more
    • Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Envoy Medical, Inc. (0001840877) (Filer)

      6/25/25 8:30:16 AM ET
      $COCH
      Industrial Specialties
      Health Care
    • Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Envoy Medical, Inc. (0001840877) (Filer)

      6/3/25 4:00:26 PM ET
      $COCH
      Industrial Specialties
      Health Care
    • Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Envoy Medical, Inc. (0001840877) (Filer)

      5/19/25 8:52:08 AM ET
      $COCH
      Industrial Specialties
      Health Care